Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria

Transplantation
Evan S DellonRaymond T Chung

Abstract

Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthetic pathway in which toxic levels of protoporphyrins often precipitate in the liver, leading to cirrhosis, liver failure, and the need for liver transplantation (OLT). Because the underlying enzyme defect in EPP is bone marrow derived, the risk for recurrent EPP allograft dysfunction is high. Although plasmapheresis may ameliorate acute allograft disease, strategies to maintain disease remission are needed. A 59-year-old man who underwent OLT for hepatic EPP experienced increased bilirubin and aminotransferases on postoperative day 700. Allograft biopsy demonstrated recurrent EPP. He was managed initially with plasmapheresis, hypertransfusion, and infusions of i.v. hematin. After normalization of liver tests, the hematin infusions have been given intermittently, are well tolerated, and associated with normal allograft function for nearly 2 years. This is the first case of the use of hematin given post-OLT to help achieve and maintain remission of allograft EPP disease.

References

Jun 1, 1975·The American Journal of Medicine·J R Bloomer Bloomer
Jul 1, 1989·Gastroenterology·J R BloomerN L Ascher
Jun 1, 1989·Clinical Biochemistry·M O Doss, M Frank
Jun 1, 1988·Gastroenterology·K O MortonJ R Bloomer
Feb 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·C J WatsonZ J Petryka
Nov 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J R Bloomer, C A Pierach
Dec 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M RankJ Bloomer
Nov 1, 1996·Journal of Pediatric Gastroenterology and Nutrition·C PotterJ Bloomer
Jul 1, 1996·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·J R BloomerR L Carithers
May 13, 1999·European Journal of Gastroenterology & Hepatology·L MeermanP L Jansen
Feb 26, 2000·Journal of Internal Medicine·S Sassa, A Kappas
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A FontanellasH de Verneuil

❮ Previous
Next ❯

Citations

Feb 9, 2011·Journal of Inherited Metabolic Disease·Joanna K DowmanUNKNOWN UK Liver Selection and Allocation Working Party
Nov 2, 2007·Clinical and Experimental Pharmacology & Physiology·Gaël Y RochefortDaniel Antier
Oct 22, 2005·The Journal of Clinical Investigation·Ikuo NakamichiM Bishr Omary
Sep 12, 2009·Orphanet Journal of Rare Diseases·Mario LechaJean-Charles Deybach
Sep 22, 2010·World Journal of Gastroenterology : WJG·María José Casanova-GonzálezRicardo Moreno-Otero
Mar 30, 2013·World Journal of Gastroenterology : WJG·Herbert L BonkovskyLaura Schrum
Nov 15, 2008·Digestive Diseases and Sciences·Simone NegriniFrancesco Indiveri
May 15, 2012·Journal of Plant Physiology·Wei XuanJin Cui
Nov 22, 2015·The Journal of Pharmacology and Experimental Therapeutics·Madhav SacharXiaochao Ma
Jul 4, 2007·Clinics in Liver Disease·Ye Htun Oo, James Neuberger
Jan 22, 2005·Transfusion·Quentin G EichbaumZbigniew M Szczepiorkowski
Oct 11, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Daisuke MoriokaKoichi Tanaka
Sep 1, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Avnish Kumar SethElwyn Elias
Nov 30, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Brendan M McGuireJoseph R Bloomer
Oct 27, 2016·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A E BharuchaA R Zinsmeister
Jun 21, 2016·Journal of Clinical Apheresis
Jun 28, 2017·Journal of Clinical Apheresis·Tina S IpeLance A Williams
Dec 4, 2009·Clinical Pharmacology and Therapeutics·A E BharuchaG Farrugia
Aug 31, 2019·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Zaid S ArdalanPaul J Gow
Sep 20, 2017·Seminars in Cardiothoracic and Vascular Anesthesia·Anthony BonaviaDmitri Bezinover
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Krishnakumar Devadas, Subhash Dhawan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.